Bison Capital - BCACU =  1/2W  + 1R

September 12, 2018, Bison Capital Acquisition Corp. (BCAC) Merger Agreement with Xynomic Pharmaceuticals, Inc DEF14A Link

 Extension Amendment 3 months to June 24 2019  - add .02/month would reach $10.55 per share, 

redemption amount of $10.49per share as of December 31, 2018

 IPO Trust= 10.25 

Trust Account ~ $63mm Feb 20 2019

Rights 1/10

1 warrant +11.50 > 1 com.  Call > 24 ---- 20 of 30 days. Can be called cashless.

5,250,000 units at 10.

Units = 1 com, 1 Right, 1/2 Warrant

Expire 3/24/19 - Deadline 21 months.

Focus Asia

EarlyBird, Chardan, Ibankers


Led by a management team experienced in technology start-up, corporate management, sales and marketing, investment banking and direct investment, Bison Capital invests in its target industries around the world. Bison Capital operates in office locations in mainland China and Hong Kong.

At December 31, 2016, our sponsor had assets of $336,195,613 and shareholders’ equity of $279,018,384 and had net income of $22,754,312 and revenues of $50,087,624 for the year ended December 31, 2016.

Bison Capital is a Hong Kong-based investment company with a focus on the media and entertainment, healthcare and financial service industries. Founded by Mr. Peixin Xu, Bison Capital has made multiple investments in film and TV production, film distribution and entertainment-related mobile Internet services, including Bona Film, Xunlei and Weiying Technologies, and Cinedigm.

No member of our management team has any previous experience with other blank check companies.

experience in sourcing, acquiring, operating, financing and selling businesses, as demonstrated by the sourcing, acquisition, investment, financing and sale of healthcare service assets such as the acquisition and sale of Beijing New Journey Cancer Care Hospital headquartered in Beijing, China in which our management team invested in 2011 and subsequently sold in 2014 and the financing of Shanghai Rainbow Children’s Clinic headquartered in Shanghai, China which established its first pediatric center in March 2014 and its second and third centers in October 2014. We believe these cases exhibit our management’s capabilities to acquire, operate and finally exit from their investments;
•         reputation for integrity and fair dealing with sellers, capital providers and target management teams;
•         experience as advisors on transactions;
•         experience in executing transactions under varying economic and financial market conditions, as demonstrated by members of our management executing investments in Bona Film Group Ltd., AirMedia Group Inc. and WeFilm (Beijing Weiying Technology Co. Ltd.) during a transitional period in the media and entertainment industries in China from traditional to technological- and digital-based media, and investments in Beijing New Journey Cancer Care Hospital and Shanghai Rainbow Children’s Clinic at the beginning stages of the specialty-specific medical care industry in China; and

June 23, 2017 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (Nasdaq:BCACU) ("Bison" or the "Company"), a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other similar business combination with one or more businesses or entities, today announced the closing of its initial public offering (IPO) of 5,250,000 units at $10.00 per unit, raising gross proceeds of $52,500,000.  The units commenced trading on Tuesday, June 20, 2017 on The NASDAQ Capital Market ("Nasdaq") under the symbol "BCACU." Each unit issued in the initial public offering consists of one ordinary share, one right to receive one-tenth of an ordinary share on the consummation of an initial business combination, and one warrant to acquire one-half of one ordinary share at $11.50 per full share. Once the securities comprising the units begin separate trading, the shares, warrants and rights are expected to be traded on Nasdaq under the symbols "BCAC," "BCACW" and "BCACR," respectively.

EarlyBirdCapital, Inc. acted as sole book-running manager for the offering and Charden, I-Bankers Securities, acted as co-manager for the offering. Bison has granted the underwriters a 30-day option to purchase up to 787,500 additional units to cover over-allotments.

Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $53,812,500 or $10.25 per unit was placed in trust. An audited balance sheet of the Company as of June 23, 2015 reflecting receipt of the proceeds upon consummation of the IPO and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the SEC.

About Bison

Bison is a blank check company, also commonly referred to as a Special Purpose Acquisition Company (SPAC), formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities. The Company's efforts to identify a target business will not be limited to a particular industry or geographic region, with focus on business located in Asia and North America in the healthcare, consumer services and media/entertainment industries. Bison is being sponsored by Bison Capital Holding Company Limited.